Literature DB >> 18810612

Role of TGF-Beta in the induction of Foxp3 expression and T regulatory cell function.

Ethan M Shevach1, Todd S Davidson, Eva N Huter, Richard A Dipaolo, John Andersson.   

Abstract

INTRODUCTION: A number of studies have suggested that transforming growth factor beta (TGF-beta) plays a critical role in immune suppression mediated by Foxp3(+) regulatory T cells. TGF-beta in concert with interleukin 2 is a potent induction factor for the differentiation of Foxp3(+) Treg from naive precursors. Polyclonal TGF-beta-induced Treg (iTreg) are capable of preventing the autoimmune syndrome that develops in scurfy mice that lack Foxp3(+) Treg. Antigen-specific iTreg can be used to both prevent and treat autoimmune gastritis that is induced by transfer of naive or primed autoantigen-specific T cells. TGF-beta complexed with latency-associated peptide is expressed on the surface of activated thymus-derived Treg. Coculture of activated Treg with naive responder T cells results in the de novo generation of fully functional Foxp3(+) T cells in a contact-dependent and TGF-beta-dependent manner. CONCLUSIONS AND SPECULATIONS: Generation of functional Foxp3(+) T cells via this pathway may represent a mechanism by which Treg maintain tolerance and expand their repertoire.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18810612     DOI: 10.1007/s10875-008-9240-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  22 in total

1.  Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells.

Authors:  Todd S Davidson; Richard J DiPaolo; John Andersson; Ethan M Shevach
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

2.  TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.

Authors:  Marika C Kullberg; Valerie Hay; Allen W Cheever; Mizuko Mamura; Alan Sher; John J Letterio; Ethan M Shevach; Ciriaco A Piccirillo
Journal:  Eur J Immunol       Date:  2005-10       Impact factor: 5.532

3.  "Infectious" transplantation tolerance.

Authors:  S Qin; S P Cobbold; H Pope; J Elliott; D Kioussis; J Davies; H Waldmann
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

4.  Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo.

Authors:  Mei-Ling Chen; Mikaël J Pittet; Leonid Gorelik; Richard A Flavell; Ralph Weissleder; Harald von Boehmer; Khashayarsha Khazaie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

5.  T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.

Authors:  Ming O Li; Yisong Y Wan; Richard A Flavell
Journal:  Immunity       Date:  2007-05-03       Impact factor: 31.745

6.  TGF-beta-induced Foxp3+ regulatory T cells rescue scurfy mice.

Authors:  Eva N Huter; George A Punkosdy; Deborah D Glass; Lily I Cheng; Jerrold M Ward; Ethan M Shevach
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

7.  A key role for TGF-beta signaling to T cells in the long-term acceptance of allografts.

Authors:  Stephen R Daley; Jianbo Ma; Elizabeth Adams; Stephen P Cobbold; Herman Waldmann
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

8.  Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta.

Authors:  K Nakamura; A Kitani; W Strober
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

9.  CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.

Authors:  Ciriaco A Piccirillo; John J Letterio; Angela M Thornton; Rebecca S McHugh; Mizuko Mamura; Hidekazu Mizuhara; Ethan M Shevach
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  29 in total

Review 1.  Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression.

Authors:  Theresa L Whiteside
Journal:  Expert Opin Biol Ther       Date:  2010-07       Impact factor: 4.388

Review 2.  The companions: regulatory T cells and gene therapy.

Authors:  Saman Eghtesad; Penelope A Morel; Paula R Clemens
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

3.  Immunosuppressive effects of the traditional Chinese herb Qu Mai on human alloreactive T cells.

Authors:  J Reid-Adam; N Yang; Y Song; P Cravedi; X-M Li; P Heeger
Journal:  Am J Transplant       Date:  2013-02-22       Impact factor: 8.086

4.  Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-β signaling.

Authors:  Ephraim A Ansa-Addo; Yongliang Zhang; Yi Yang; George S Hussey; Breege V Howley; Mohammad Salem; Brian Riesenberg; Shaoli Sun; Don C Rockey; Serhan Karvar; Philip H Howe; Bei Liu; Zihai Li
Journal:  J Clin Invest       Date:  2017-03-13       Impact factor: 14.808

5.  Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy.

Authors:  Md Selim Ahmed; Se Eun Byeon; Yideul Jeong; Mohammad Alam Miah; Md Salahuddin; Yoon Lee; Sung-Soo Park; Yong-Soo Bae
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

6.  Rap1A regulates generation of T regulatory cells via LFA-1-dependent and LFA-1-independent mechanisms.

Authors:  Lequn Li; Jin sub Kim; Vassiliki A Boussiotis
Journal:  Cell Immunol       Date:  2010-09-22       Impact factor: 4.868

7.  Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis.

Authors:  Christian Klemann; Benjamin J E Raveney; Anna K Klemann; Tomoko Ozawa; Stephan von Hörsten; Koichi Shudo; Shinji Oki; Takashi Yamamura
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

8.  Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice.

Authors:  Bruce Turpie; Takeru Yoshimura; Abha Gulati; Jose David Rios; Darlene A Dartt; Sharmila Masli
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

9.  CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta.

Authors:  Paul L Bollyky; Ben A Falk; S Alice Long; Anton Preisinger; Kathy R Braun; Rebecca P Wu; Stephen P Evanko; Jane H Buckner; Thomas N Wight; Gerald T Nepom
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

10.  A pilot study showing associations between frequency of CD4(+) memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes.

Authors:  Rosita Moya; Hannah Kathryn Robertson; Dawson Payne; Aditi Narsale; Jim Koziol; Joanna Davida Davies
Journal:  Clin Immunol       Date:  2016-04-22       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.